Table 4 Relative intensities of metabolites at pre- and post-treatment
From: Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Pre-treatment (mean ± SE) | Post-treatment (mean ± SE) | ||||||
|---|---|---|---|---|---|---|---|
Metabolites | ppm | Survivors | Non-survivors | p-value | Survivors | Non-survivors | p-value |
Lactate | 4.08-4.13 | 185.8 ± 11.4 | 164.6 ± 13.8 | 0.534 | 196.2 ± 12.7 | 250.6 ± 26.0 | 0.089 |
Glycine | 3.54-3.56 | 115.0 ± 6.4 | 120.8 ± 11.0 | 0.542 | 91.2 ± 4.1 | 111.4 ± 8.4 | 0.033* |
GPC | 3.22-3.24 | 167.3 ± 12.4 | 170.1 ± 23.9 | 0.949 | 115.6 ± 6.7 | 153.9 ± 24.1 | 0.144 |
PC | 3.21-3.22 | 247.9 ± 17.0 | 285.4 ± 34.9 | 0.338 | 158.0 ± 16.1 | 205.5 ± 28.1 | 0.105 |
Cho | 3.20-3.21 | 95.4 ± 3.9 | 108.7 ± 8.3 | 0.225 | 79.5 ± 3.7 | 85.9 ± 6.2 | 0.276 |
tCho | 3.20-3.24 | 498.3 ± 26.4 | 551.3 ± 46.8 | 0.253 | 344.9 ± 22.3 | 434.6 ± 44.6 | 0.075 |
Taurine | 3.40-3.43 | 242.6 ± 9.6 | 222.8 ± 12.4 | 0.393 | 248.0 ± 8.1 | 222.3 ± 9.3 | 0.144 |
β-Glucose | 4.61-4.64 | 48.4 ± 3.3 | 49.3 ± 6.0 | 1.000 | 63.6 ± 4.3 | 53.5 ± 6.6 | 0.172 |